MarketCapExport financials
Caleres (CAL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Caleres Financial Ratios 2026-2009 | CAL
Brief overview of Caleres's valuation and returns
The review covers five available annual periods spanning 2020 to 2025.
Market valuation is represented by P/E 5.57x (median 5.69x), EV/EBITDA 5.84x (median 2.96x), P/S 0.13x (median 0.25x). Multiples are on average 40.2% below their own medians. Shares look cheaper than their recent historical valuation.
Earnings yield calculated as 1/P/E is about 17.9%, showing current profit per unit of share price.
End-period return metrics are ROE -1.6%, ROA -0.5%, ROCE 0.6%. Negative returns point to losses or poor capital efficiency. Valuation multiples are less informative in this setting.
PEG of 0.71x shows valuation is not outpacing embedded growth. The conclusion depends on earnings durability.
The cash conversion cycle increased 34.8 days to 106.8 days, weakening working-capital efficiency.
Valuation takeaway
Caleres's discount may reflect genuine profitability issues rather than market inefficiency alone.
Annual Financial Ratios Caleres
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35.4 | 5.6 | 7.6 | 4.2 | 5.7 | -1.8 | 7.0 | -234.4 | 13.8 | 19.7 | 14.8 | 15.6 | 26.5 | 24.6 | 17.9 | 17.7 | - | - | |
P/S |
0.1 | 0.2 | 0.5 | 0.3 | 0.3 | 0.4 | 0.2 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | - | - |
EPS |
-0.2 | 3.1 | 4.8 | 5.0 | 3.6 | -11.8 | 1.5 | -0.1 | 2.0 | 1.5 | 1.9 | 1.9 | 0.9 | 0.6 | 0.6 | 0.8 | 0.2 | - |
EV (Enterprise Value) |
319 M | 562 M | 1.28 B | 713 M | 755 M | 682 M | 2.18 B | 2.45 B | 1.91 B | 2.1 B | 1.79 B | 1.9 B | 1.6 B | 1.35 B | 1.21 B | 1.27 B | -126 M | -86.9 M |
EBITDA per Share |
1.68 | 5.69 | 7.26 | 7.54 | 7.03 | -11.4 | 4.25 | 1.51 | 4.57 | 3.61 | 4.12 | 4.3 | 3.69 | 2.85 | 2.24 | 2.89 | - | - |
EV/EBITDA |
5.8 | 3.0 | 5.2 | 2.7 | 2.9 | -1.5 | 5.1 | 28.3 | 7.0 | 10.2 | 7.3 | 7.9 | 7.4 | 7.8 | 8.5 | 7.2 | -1.9 | - |
PEG |
0.71 | -0.05 | -0.11 | -0.05 | -0.07 | 0.04 | 0.01 | 2.21 | 0.41 | -1.07 | 27.8 | 0.14 | 0.74 | 1.73 | -0.55 | 0.06 | - | - |
P/B |
0.2 | 0.3 | 0.7 | 0.4 | 0.4 | 0.4 | 0.7 | 2.0 | 1.7 | 2.1 | 2.0 | 2.4 | 2.1 | 1.6 | 1.1 | 1.6 | - | - |
P/CF |
3.4 | 5.7 | 6.5 | 5.9 | 4.7 | 6.1 | 3.7 | 20.3 | 8.6 | 10.4 | 17.8 | 347.8 | 18.4 | 5.0 | 46.3 | -11.5 | - | - |
ROE % |
-1.64 | 17.71 | 30.65 | 42.72 | 43.37 | -215.41 | 9.73 | -0.86 | 12.15 | 10.71 | 13.55 | 15.30 | 7.99 | 6.47 | 5.96 | 8.96 | 2.31 | - |
ROA % |
-0.50 | 5.60 | 9.52 | 9.78 | 7.49 | -23.52 | 2.58 | -0.30 | 5.85 | 4.45 | 6.25 | 6.81 | 3.31 | 2.35 | 2.00 | 3.24 | - | - |
ROCE % |
0.57 | 13.26 | 18.43 | 23.30 | 25.30 | -50.51 | 6.57 | 0.02 | 12.05 | 10.13 | 13.63 | 15.79 | 12.93 | 8.77 | 4.91 | 11.43 | 7.67 | - |
Current Ratio |
- | - | - | - | - | - | 1.0 | 1.1 | 2.0 | 1.6 | 2.2 | 2.0 | 2.0 | 1.6 | 1.6 | 1.6 | - | - |
DSO |
20.1 | 19.9 | 17.7 | 15.7 | 16.4 | 24.9 | 21.0 | 25.3 | 20.0 | 23.0 | 23.3 | 19.5 | 19.2 | 18.1 | 22.5 | 18.1 | - | - |
DIO |
136.4 | 134.5 | 131.6 | 127.6 | 127.7 | 151.8 | 129.9 | 148.6 | 128.5 | 140.9 | 130.5 | 129.4 | 133.3 | 122.6 | 129.3 | 127.5 | - | - |
DPO |
49.7 | 59.5 | 56.6 | 60.9 | 72.0 | 75.1 | 56.1 | 68.8 | 61.6 | 64.1 | 56.7 | 51.5 | 55.2 | 51.2 | 43.9 | 40.7 | - | - |
Operating Cycle |
156.5 | 154.4 | 149.3 | 143.3 | 144.1 | 176.7 | 151.0 | 173.9 | 148.5 | 163.9 | 153.8 | 148.9 | 152.5 | 140.7 | 151.8 | 145.6 | - | - |
Cash Conversion Cycle |
106.8 | 94.9 | 92.7 | 82.4 | 72.0 | 101.6 | 94.9 | 105.1 | 86.9 | 99.9 | 97.1 | 97.5 | 97.3 | 89.5 | 107.9 | 105.0 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Financial Ratios Caleres
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.07 | 0.2 | 0.42 | - | 0.2 | 0.21 | - | 1.2 | 0.85 | 0.88 | - | 1.32 | 0.95 | 0.97 | - | 1.09 | 1.4 | 1.34 | - | 1.56 | 0.98 | 0.16 | 0.01 | 0.38 | -0.83 | -8.95 | -1.83 | 0.69 | 0.61 | 0.22 | 0.47 | 0.68 | 0.55 | 0.4 | -0.16 | 0.8 | 0.41 | 0.35 | 0.26 | 0.81 | 0.46 | 0.41 | 0.37 | 0.78 | 0.38 | 0.44 | 0.14 | 0.76 | 0.41 | 0.35 | 0.09 | 0.63 | 0.36 | -0.26 | -0.21 | 0.57 | -0.06 | 0.04 | - | 0.8 | -0.11 | 0.08 |
EBITDA per Share |
1.45 | 0.37 | 1.1 | - | 0.37 | 0.69 | - | 1.78 | 1.34 | 1.54 | - | 1.99 | 1.54 | 1.69 | - | 1.65 | 2.04 | 2.05 K | - | 2.9 K | 2.17 K | 731 | - | 1.42 K | -61 | -10.7 K | - | 1.98 K | 1.52 K | 0.69 | - | 1.74 K | 1.29 K | 0.81 | - | 2.03 | 1.23 | 0.82 | - | 2 | 1.2 | 0.89 | - | 1.86 | 1.26 | 0.92 | - | 1.88 | 1.15 | 0.89 | - | 1.72 | 0.98 | 0.72 | - | 1.62 | 0.62 | 0.51 | - | 1.5 | 0.42 | - |
ROE % |
4.98 | 5.74 | 11.50 | 9.17 | 14.11 | 18.44 | 17.29 | 26.43 | 26.81 | 29.64 | 24.22 | 34.07 | 38.43 | 45.47 | 37.69 | 57.49 | 63.18 | 52.71 | 38.37 | 38.43 | 24.25 | -3.97 | -129.51 | -141.47 | -142.79 | -126.04 | -2.09 | 12.64 | 12.15 | 11.30 | 12.27 | 8.36 | 9.65 | 9.19 | 9.18 | 12.15 | 12.42 | 12.89 | 13.42 | 14.53 | 14.81 | 14.55 | 15.10 | 13.39 | 13.86 | 14.45 | 14.11 | 13.77 | 13.69 | 13.75 | 8.00 | 5.06 | 4.64 | 0.41 | 3.43 | 13.48 | 6.67 | 8.17 | 7.76 | 8.06 | -1.18 | 0.88 |
ROA % |
1.46 | 1.71 | 3.50 | 2.79 | 4.28 | 5.63 | 5.26 | 7.83 | 7.50 | 7.92 | 6.26 | 8.28 | 8.23 | 9.07 | 7.16 | 10.34 | 10.37 | 8.18 | 5.56 | 5.58 | 3.11 | -0.39 | -16.28 | -20.40 | -19.98 | -17.57 | -1.65 | 3.82 | 4.14 | 4.58 | 5.36 | 3.54 | 4.50 | 4.22 | 4.13 | 5.45 | 5.71 | 5.99 | 6.38 | 6.84 | 6.88 | 6.67 | 6.88 | 6.08 | 6.12 | 6.33 | 6.07 | 5.87 | 5.65 | 5.55 | 3.17 | 2.16 | 1.73 | 0.23 | 1.36 | 4.78 | 2.35 | 2.85 | 2.70 | 2.75 | -0.34 | 0.30 |
ROCE % |
4.81 | 4.79 | 8.93 | 6.82 | 10.51 | 13.61 | 12.58 | 19.07 | 19.39 | 21.01 | 17.09 | 23.05 | 24.34 | 26.82 | 21.51 | 31.68 | 33.10 | 27.24 | 19.47 | 21.36 | 8.98 | -35.69 | -37.60 | -34.84 | -34.31 | -31.03 | 6.25 | 9.77 | 9.94 | 9.68 | 8.61 | 13.60 | 13.00 | 12.52 | 10.36 | 16.20 | 14.72 | 14.96 | 12.51 | 18.30 | 16.59 | 16.65 | 13.49 | 19.98 | 18.16 | 17.76 | 14.19 | 20.29 | 17.06 | 16.08 | 12.36 | 18.05 | 13.19 | 11.74 | 8.74 | 13.44 | 7.59 | 8.21 | 6.41 | 4.70 | -0.15 | 1.87 |
DSO |
18.3 | 21.5 | 22.6 | - | 20.5 | 22.4 | - | 20.1 | 21.1 | 20.6 | - | 17.9 | 18.7 | 19.3 | - | 16.5 | 19.1 | 19.1 | - | 15.8 | 16.4 | 21.1 | 19.8 | 17.7 | 23.2 | 38.7 | 22.0 | 18.6 | 19.2 | 20.3 | - | 987.7 | 456.5 | 20.1 | - | 829.1 | 383.1 | 809.1 | - | 639.9 | 389.7 | 743.5 | - | 635.2 | 374.7 | 673.4 | - | 446.1 | 292.0 | 482.1 | - | 204.5 | 152.6 | 306.4 | - | 172.8 | 187.4 | - | - | - | - | - |
DIO |
136.0 | 159.4 | 152.6 | - | 155.1 | 151.5 | - | 137.4 | 146.0 | 144.8 | - | 131.7 | 146.0 | 144.4 | - | 141.3 | 160.7 | 126.5 | - | 112.7 | 130.6 | 133.4 | - | 126.4 | 166.0 | 210.2 | - | 138.7 | 147.2 | 139.6 | - | 138.7 | 142.9 | 148.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
50.7 | 59.6 | 55.6 | - | 62.3 | 63.1 | - | 72.2 | 81.3 | 64.8 | - | 65.7 | 73.2 | 62.3 | - | 67.6 | 89.3 | 74.6 | - | 71.2 | 82.9 | 70.3 | - | 66.1 | 82.7 | 101.7 | - | 69.9 | 75.4 | 64.4 | - | 70.4 | 73.8 | 68.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 180.9 | - | - | 175.6 | 182.7 | - | 157.6 | 167.1 | 164.2 | - | 149.5 | 164.7 | 163.8 | - | 157.8 | 179.8 | 145.6 | - | 128.6 | 147.0 | 154.5 | 19.8 | 144.2 | 189.3 | 248.9 | 22.0 | 157.3 | 166.3 | 159.9 | - | 1126.3 | 599.5 | 169.0 | - | 829.1 | 383.1 | 809.1 | - | 639.9 | 389.7 | 743.5 | - | 635.2 | 374.7 | 673.4 | - | 446.1 | 292.0 | 482.1 | - | 204.5 | 152.6 | 306.4 | - | 172.8 | 187.4 | - | - | - | - | - |
Cash Conversion Cycle |
- | 121.3 | - | - | 113.3 | 118.7 | - | 85.4 | 85.8 | 95.8 | - | 83.8 | 91.5 | 101.5 | - | 90.3 | 90.5 | 71.0 | - | 57.3 | 64.0 | 84.2 | 19.8 | 78.0 | 106.6 | 147.2 | 22.0 | 87.4 | 91.0 | 95.4 | - | 1055.9 | 525.6 | 100.6 | - | 829.1 | 383.1 | 809.1 | - | 639.9 | 389.7 | 743.5 | - | 635.2 | 374.7 | 673.4 | - | 446.1 | 292.0 | 482.1 | - | 204.5 | 152.6 | 306.4 | - | 172.8 | 187.4 | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Multiples are an important financial analysis tool for the company Caleres, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Footwear industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Deckers Outdoor Corporation
DECK
|
$ 89.81 | -0.69 % | $ 13.1 B |  USA |
 |
Skechers U.S.A.
SKX
|
- | - | $ 9.59 B | USA |
 |
NIKE
NKE
|
$ 38.66 | -3.07 % | $ 57.2 B | USA |
 |
Обувь России
OBUV
|
- | - | - |  Russia |
 |
Rocky Brands
RCKY
|
$ 53.66 | 0.02 % | $ 401 M | USA |
 |
Vera Bradley
VRA
|
$ 8.03 | -0.25 % | $ 224 M | USA |
 |
Crocs
CROX
|
$ 159.89 | -0.21 % | $ 8.67 B | USA |
 |
Steven Madden, Ltd.
SHOO
|
$ 42.56 | -0.65 % | $ 3.09 B | USA |
 |
Wolverine World Wide
WWW
|
$ 21.61 | -1.59 % | $ 1.77 B | USA |
 |
Weyco Group
WEYS
|
$ 60.06 | -1.16 % | $ 569 M | USA |
 |
Foot Locker
FL
|
- | -0.37 % | $ 2.26 B | USA |
 |
Forward Industries
FORD
|
- | - | $ 10 M | USA |